Family Medicine Doctors in Goodland, KS Accepting Medicare
3 Family Medicine doctors found. Showing 1 - 3
 Dr. Travis M Daise, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 106 Willow Rd, Goodland, KS 67735 Phone: 785-890-6075 Fax: 785-890-6077 |
 Kali Rubenthaler-brunkhardt, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 106 Willow Rd, Goodland, KS 67735 Phone: 785-890-4012 Fax: 785-890-6077 |
Dr. Mohedine Shafei, M.D. Family Medicine Medicare: Medicare Enrolled Practice Location: 106 Willow Rd, Goodland, KS 67735 Phone: 785-890-6075 Fax: 785-890-6077 |
News Archive
Study reveals six-month consequences of COVID-19 in patients discharged from hospital
More than three quarters of COVID-19 patients have at least one ongoing symptom six months after initially becoming unwell, according to research published in The Lancet.
Obese patients with type 2 diabetes should be prioritised for obesity surgery over those without diabetes
New research published in The Lancet Diabetes & Endocrinology suggests that, when considering overall costs of healthcare, obese patients with type 2 diabetes, especially those with recent disease onset, should be prioritised for obesity surgery over those without type 2 diabetes, since many patients see a reversal of diabetes after surgery and thus need fewer expensive diabetes medications or treatment for complications in future.
ViroPharma announces data on safety, efficacy of Cinryze to treat acute angioedema attacks
ViroPharma Incorporated today announced that data from Phase 3 studies of Cinryze (C1 esterase inhibitor [human]) have been published in the August 5, 2010 issue of the New England Journal of Medicine. The paper entitled Nanofiltered C1 Inhibitor Concentrate for Treatment of Hereditary Angioedema by Dr. Bruce L. Zuraw et al. describes the safety and efficacy of Cinryze in treating and preventing attacks of hereditary angioedema. Cinryze is the first and only FDA-approved C1 esterase inhibitor therapy indicated for routine prophylaxis against angioedema attacks in adolescent and adult patients with hereditary angioedema (HAE), a rare, debilitating and potentially fatal disease; it is not approved by the FDA to treat acute angioedema attacks.
First Edition: August 2, 2011
Today's headlines reveal how some specific elements of the debt-ceiling deal might impact Medicare providers.
› Verified 8 days ago